222 related articles for article (PubMed ID: 10342012)
1. The hereditary forms of pancreatic neuroendocrine tumors.
DeLellis RA
Adv Anat Pathol; 1999 May; 6(3):149-53. PubMed ID: 10342012
[TBL] [Abstract][Full Text] [Related]
2. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM
Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638
[TBL] [Abstract][Full Text] [Related]
4. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
5. Microadenomatosis of the pancreas in von Hippel-Lindau disease.
Chetty R; Ezzat S; Asa SL
Am J Surg Pathol; 2006 Dec; 30(12):1630; author reply 1630-1. PubMed ID: 17122523
[No Abstract] [Full Text] [Related]
6. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
Montera M; Bellone E; Ajmar F; Mandich P
Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
[No Abstract] [Full Text] [Related]
7. Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
Los M; Kerckhaert OA; Zewald R; van Amstel HK; Voest EE
J Natl Cancer Inst; 2000 Oct; 92(20):1688-9. PubMed ID: 11036115
[No Abstract] [Full Text] [Related]
8. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
9. [Von Hippel-Lindau disease type 2-related pancreatic neuroendocrine tumor and adrenal myelolipoma].
Dolzhansky OV; Morozova MM; Korostelev SA; Kanivets IV; Chardarov NK; Shatveryan GA; Paltseva EM; Fedorov DN
Arkh Patol; 2016; 78(1):36-41. PubMed ID: 26978235
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
[TBL] [Abstract][Full Text] [Related]
11. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
12. Von Hippel-Lindau disease: how does one gene cause multiple tumors?
Roach ES
Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528
[No Abstract] [Full Text] [Related]
13. Triple pancreatic lesion in a patient with Von Hippel-Lindau disease.
López Marcano AJ; Ramia Ángel JM; de la Plaza Llamas R; Al-Swely F; Manuel Vázquez A; García Amador C; Candia A
Gastroenterol Hepatol; 2018; 41(7):446-448. PubMed ID: 28882614
[No Abstract] [Full Text] [Related]
14. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.
Moore PS; Missiaglia E; Antonello D; Zamò A; Zamboni G; Corleto V; Falconi M; Scarpa A
Genes Chromosomes Cancer; 2001 Oct; 32(2):177-81. PubMed ID: 11550286
[TBL] [Abstract][Full Text] [Related]
15. Von Hippel-Lindau tumor suppressor protein and transcription elongation: new insights into regulation of gene expression.
Bertherat J
Eur J Endocrinol; 1996 Feb; 134(2):157, 159. PubMed ID: 8630511
[No Abstract] [Full Text] [Related]
16. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
[TBL] [Abstract][Full Text] [Related]
18. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
19. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
20. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
